Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0000875045-18-000005
Filing Date
2018-02-01
Accepted
2018-02-01 16:35:03
Documents
193
Period of Report
2017-12-31

Document Format Files

Seq Description Document Type Size
1 10-K biib-20171231x10k.htm 10-K 4142574
2 EXHIBIT 10.10 biib-20171231xex1010.htm EX-10.10 27576
3 EXHIBIT 10.11 biib-20171231xex1011.htm EX-10.11 27456
4 EXHIBIT 10.28 biib-20171231xex1028.htm EX-10.28 16293
5 EXHIBIT 10.31 biib-20171231xex1031.htm EX-10.31 74606
6 EXHIBIT 10.32 biib-20171231xex1032.htm EX-10.32 39717
7 EXHIBIT 10.33 biib-20171231xex1033.htm EX-10.33 321097
8 EXHIBIT 21 biib-20171231xex21.htm EX-21 59453
9 EXHIBIT 23 biib-20171231xex23.htm EX-23 2658
10 EXHIBIT 31.1 biib-20171231xex311.htm EX-31.1 13956
11 EXHIBIT 31.2 biib-20171231xex312.htm EX-31.2 14299
12 EXHIBIT 32.1 biib-20171231xex321.htm EX-32.1 6575
19 acquiredinprocessrdchart.jpg GRAPHIC 17454
20 amortofacqintanassetschart.jpg GRAPHIC 19882
21 anticd20revenueschart.jpg GRAPHIC 45295
22 avonex.jpg GRAPHIC 5670
23 benepalia02.jpg GRAPHIC 5283
24 biogenidec.jpg GRAPHIC 11141
25 biogenlogostandarda06.jpg GRAPHIC 95885
26 biosimilarschart.jpg GRAPHIC 20890
27 collabprofitsharechart.jpg GRAPHIC 18726
28 corporatestrategy.jpg GRAPHIC 37006
29 costofsaleschart.jpg GRAPHIC 32446
30 equityinlossofinvesteechart.jpg GRAPHIC 18186
31 fampyra.jpg GRAPHIC 2031
32 financialhighlightschart.jpg GRAPHIC 34559
33 flixabi.jpg GRAPHIC 5565
34 fumaderm.jpg GRAPHIC 3140
35 gazyva.jpg GRAPHIC 21759
36 geographicsaleschart.jpg GRAPHIC 34372
37 glonfvcontconsideration.jpg GRAPHIC 18937
38 incometaxprovisionchart.jpg GRAPHIC 35385
39 interferonchart.jpg GRAPHIC 36664
40 noncontrollinginterestchart.jpg GRAPHIC 19938
41 ocrevusmultiplesclerosislogo.jpg GRAPHIC 10027
42 oiechart.jpg GRAPHIC 20272
43 otherrevenueschart.jpg GRAPHIC 31270
44 part1researchanddevchart.jpg GRAPHIC 20758
45 plegridy.jpg GRAPHIC 5127
46 principalproductschart.jpg GRAPHIC 70489
47 rdpiechart2015.jpg GRAPHIC 35703
48 rdpiechart2016.jpg GRAPHIC 36799
49 rdpiechart2017.jpg GRAPHIC 37393
50 researchanddevelopmentchart.jpg GRAPHIC 70608
51 reserveschart.jpg GRAPHIC 33492
52 restructuringchargeschart.jpg GRAPHIC 19001
53 rituxan.jpg GRAPHIC 9985
54 sellinggeneraladminchart.jpg GRAPHIC 20779
55 spinrazachart.jpg GRAPHIC 24256
56 spinrazalogonewa01.jpg GRAPHIC 72059
57 stockperformancechart.jpg GRAPHIC 63262
58 tecfidera.jpg GRAPHIC 7384
59 tecfiderachart.jpg GRAPHIC 35340
60 teclitigationchart.jpg GRAPHIC 18080
61 tysabri.jpg GRAPHIC 6359
62 tysabrichart.jpg GRAPHIC 36944
63 zinbryta.jpg GRAPHIC 4850
64 zinbrytachart.jpg GRAPHIC 21065
  Complete submission text file 0000875045-18-000005.txt   22881028

Data Files

Seq Description Document Type Size
13 XBRL INSTANCE DOCUMENT biib-20171231.xml EX-101.INS 4971313
14 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT biib-20171231.xsd EX-101.SCH 120700
15 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT biib-20171231_cal.xml EX-101.CAL 152081
16 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT biib-20171231_def.xml EX-101.DEF 677137
17 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT biib-20171231_lab.xml EX-101.LAB 1576222
18 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT biib-20171231_pre.xml EX-101.PRE 1020896
Mailing Address 225 BINNEY STREET CAMBRIDGE MA 02142
Business Address 225 BINNEY STREET CAMBRIDGE MA 02142 7814642000
BIOGEN INC. (Filer) CIK: 0000875045 (see all company filings)

EIN.: 330112644 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-19311 | Film No.: 18567291
SIC: 2836 Biological Products, (No Diagnostic Substances)